Song Kyung Soon, Kim Hyun Kyung, Song Jae Woo
Department of Clinical Pathology, Yonsei University Medical Center, Seoul, Korea.
Haematologica. 2002 Oct;87(10):1062-7.
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation leading to the widespread deposition of fibrin in the circulation. Therefore, the determination of soluble fibrin is crucial for the diagnosis of DIC. Thrombus precursor protein (TpP) levels can be determined as a measure of soluble polymers, which are the immediate precursors of insoluble fibrin. In this study, the potential diagnostic usefulness of this TpP test was investigated in septic patients with DIC and liver diseases.
TpP analysis was performed on 155 plasma samples from 95 septic patients, including 72 patients without liver disease and 23 patients with liver diseases, and on 42 plasma samples from normal healthy subjects. The study population was subdivided according to three phases of DIC described as compensated, decompensated and full-blown DIC. Plasma TpP level was determined using a new assay, the TpPTM (American Biogenetic Sciences, USA), which is based on an ELISA method.
Septic patients with decompensated (16.1 9.1 mg/mL) or full- blown (20.9 12.4 mg/mL) phases of DIC had significantly higher TpP levels than those with the compensated (5.6 6.2 mg/mL) phase of DIC or healthy controls (2.9 1.6 mg/mL). In septic patients with liver disease, a significant difference was found between the TpP levels of patients with full- blown DIC (21.6 10.6 mg/mL) and those of patients with the decompensated phase (13.4 6.5 mg/mL). Plasma TpP levels correlated significantly with other DIC parameters including platelet count, fibrinogen, antithrombin and TAT, and correlated weakly with D-dimer.
Our findings indicate that septic patients who developed decompensated or full-blown DIC or organ dysfunction have significantly higher plasma levels of TpP, and suggest the potential usefulness of the TpP assay as an aid to the diagnosis of DIC in cases of sepsis and liver disease complicated by sepsis.
弥散性血管内凝血(DIC)是一种以全身血管内凝血激活导致纤维蛋白在循环中广泛沉积为特征的综合征。因此,可溶性纤维蛋白的测定对DIC的诊断至关重要。血栓前体蛋白(TpP)水平可作为可溶性聚合物的一项检测指标,这些聚合物是不溶性纤维蛋白的直接前体。在本研究中,对患有DIC的脓毒症患者及肝病患者进行了TpP检测的潜在诊断价值研究。
对95例脓毒症患者的155份血浆样本进行TpP分析,其中包括72例无肝病患者和23例肝病患者,同时对42份正常健康受试者的血浆样本进行分析。研究人群根据DIC的三个阶段进行细分,分别为代偿期、失代偿期和重症期DIC。采用一种基于ELISA方法的新型检测方法TpPTM(美国生物遗传科学公司,美国)测定血浆TpP水平。
处于失代偿期(16.1±9.1mg/mL)或重症期(20.9±12.4mg/mL)的脓毒症DIC患者的TpP水平显著高于代偿期(5.6±6.2mg/mL)的患者或健康对照组(2.9±1.6mg/mL)。在患有肝病的脓毒症患者中,重症期DIC患者(21.6±10.6mg/mL)与失代偿期患者(13.4±6.5mg/mL)的TpP水平存在显著差异。血浆TpP水平与其他DIC参数显著相关,包括血小板计数、纤维蛋白原、抗凝血酶和凝血酶 - 抗凝血酶复合物(TAT),与D - 二聚体相关性较弱。
我们的研究结果表明,发生失代偿期或重症期DIC或器官功能障碍的脓毒症患者血浆TpP水平显著升高,提示TpP检测在脓毒症及合并脓毒症的肝病病例中对DIC诊断的潜在价值。